Results 81 to 90 of about 1,041,172 (171)
The global monkeypox virus (MPXV) outbreak in 2022 emphasizes the urgent need for effective and accessible new-generation vaccines and neutralizing antibodies. Herein, we identified MPXV-neutralizing antibodies using high-throughput single-cell RNA and V(
Ruitian Hou +8 more
doaj +1 more source
Identification of Repurposed Drugs Against Monkeypox Virus Through Comprehensive Virtual Screening
Graphical Abstract and Lay Summary By combining interspecies protein analysis with advanced virtual screening, this study identifies potent repurposed drug candidates—including vindesine and LY2090314—targeting mpox DNA topoisomerase and polymerase. This workflow provides a rapid, practical framework for antiviral discovery against emerging infectious ...
Taeho Yu, Woo Dae Jang, Sang Yup Lee
wiley +1 more source
Monkeypox: Uma zoonose de preocupação mundial
A monkeypox é uma doença zoonótica de origem africana, causada pelo vírus monkeypox (MPXV), pertencente à família Poxviridae. Inicialmente descoberto na década de 1958, o surto registrado em 2022 compreende a doença em sua maior distribuição mundial ...
Ana Carolina Leal da Cruz Lisboa +3 more
doaj +1 more source
Strategy of developing nucleic acid-based universal monkeypox vaccine candidates
Until May 2022, zoonotic infectious disease monkeypox (MPX) caused by the monkeypox virus (MPXV) was one of the forgotten viruses considered to be geographically limited in African countries even though few cases outside of Africa were identified ...
Dimitri Papukashvili +5 more
doaj +1 more source
ABSTRACT Background HIV causes immunosuppression by targeting CD4+ T lymphocytes, which may influence susceptibility and clinical outcomes of coinfections such as the Mpox virus (MPXV). Despite conflicting evidence, understanding the relationship between CD4 counts and MPXV severity in people living with HIV (PLWH) remains critical.
Kesaobaka Batisani +21 more
wiley +1 more source
High‐affinity monoclonal antibodies (mAbs) targeting the MPXV EEV protein A35R were rapidly isolated using mRNA‐LNP vaccination and the Beacon single‐cell sorting Optofluidic platform, followed by functional profiling. One mAb, 17H1, potently neutralized authentic MPXV and conferred complete protection in vivo.
Shimeng Bai +10 more
wiley +1 more source
There is no effective method to treat this virus and prevent its transmission. To address this, we have developed a nano‐silver‐selenium liquid dressing (AgSe@LD) by combining silver and selenium nanoparticles with commercial liquid dressings. This unique AgSe@LD formulation exhibits good adhesion, stability and toughness and demonstrates efficient ...
Wei Wang +15 more
wiley +1 more source
Severe Scrotal Cellulitis in a Young Man
JEADV Clinical Practice, EarlyView.
Hamad El Hajj +3 more
wiley +1 more source
Human judgment forecasts of human monkeypox transmission and burden in non-endemic countries
Background: An increase in reported human infections by the monkeypox virus (MPXV) has been observed in multiple non-endemic countries. Forecasts of transmission and disease burden associated with MPXV can support public health decision making.
Gaia Dempsey +12 more
core +1 more source
ABSTRACT Background and Aims The Monkeypox (Mpox) virus is a zoonotic Orthopoxvirus with a global outbreak that began in 2022, with more than 132,000 confirmed cases and 1500 deaths across over 128 countries. The pandemic preparedness pipeline emphasizes the importance of diagnostic surveillance of pathogens in at‐risk populations to monitor ...
Roland Ngwese Akwelle +20 more
wiley +1 more source

